These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11898959)

  • 21. Dyslipidaemia in diabetic patients: time for a rethink.
    Shepherd J
    Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The national cholesterol education program adult treatment panel ill guidelines.
    Clearfield MB
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S1-5. PubMed ID: 12572622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin.
    Ito MK
    Ann Pharmacother; 2004 Feb; 38(2):277-85. PubMed ID: 14742767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of cholesterol in coronary heart disease risk reduction.
    Woodhead GA
    Nurse Pract; 1996 Sep; 21(9):45, 48, 51-3. PubMed ID: 8884794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
    Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
    Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment.
    Hyre AD; Fox CS; Astor BC; Cohen AJ; Muntner P
    Am J Kidney Dis; 2007 Jan; 49(1):37-45. PubMed ID: 17185144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
    Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of hypolipidaemic drugs.
    Reckless JP
    Postgrad Med J; 1993; 69 Suppl 1():S30-3. PubMed ID: 8497454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
    Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When do we treat hypercholesterolemia?
    Brown WV
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III10-4; discussion III 15-7. PubMed ID: 1477992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol management: guidelines have changed, although diet is still central.
    Stoy DB
    AAOHN J; 1994 Mar; 42(3):102-7. PubMed ID: 8147994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDL cholesterol: physiology, pathophysiology, and management.
    Link JJ; Rohatgi A; de Lemos JA
    Curr Probl Cardiol; 2007 May; 32(5):268-314. PubMed ID: 17481993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underidentification and undertreatment of dyslipidemia.
    Clearfield MB
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S5-8. PubMed ID: 12572623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of hypercholesterolemia revisited.
    Wiggins BS
    Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.